The F595A homolog in JAK1, F636A, blocks constitutive activity of JAK1 V658F. by Alexandra Dusa (247246)

“…<p>Transient transfection in the JAK1-deficient U4C cell line indicates a decrease in the STAT3 transcriptional activity in the JAK1 F636A/V658F, as compared to JAK1 V658F.…”

Fig 5 - by Timothy P. Szczykutowicz (11614088)

Higher Cell Seeding Density Decreases Cell Cycle Progression. by Blair K. Gage (241218)

Knockdown of Tsg101 and Alix decrease the production of infectious OROV. by Natalia S. Barbosa (5172338)

The effects of NAC on the decreased number of myotube formations caused by arecoline. by Yi-Xuan Li (6633845)

Treatment with LY-294002 decreases expression of anti-inflammatory cytokines. by Crystal Rocher (500661)

ASD scores decrease significantly with age within the ADHD groups. by Laurence O’Dwyer (290940)

Data_Sheet_1_Nitric Oxide Releasing Hydrogel Nanoparticles Decreases Epithelial Cell Injuries Associated With Airway Reopening.docx by Samar Shurbaji (9938696)

Is there any relation between anthropometric indices and decrease in seminal parameters? by Juliana Christofolini (6851441)

Upregulation of astroglial Cx30 decreased LTP and recognition memory. by Eléonore Hardy (15208385)

“…LTP maintenance for the last 10 min (30–40 min) was decreased for AAV-GFAP-Cx30 (<i>n =</i> 9 slices from 5 mice) compared to AAV-GFAP-GFP (<i>n</i> = 8 slices from 5 mice); *<i>p</i> < 0.05, Welch’s <i>t</i> test). …”

DC depletion decreases bacterial load upon bacterial infection. by Stella E. Autenrieth (182751)

Expression of WT Dyskerin can rescue dysfunctional telomerase in <i>ΔL37</i> cells but not in <i>A353V</i> cells. by Bai-Wei Gu (740949)

Prenatal treatment decreases proliferation and increases apoptosis in small intestine. by Fátima Ramalhosa (3095712)

“…(B) Proliferation rate is decreased within the crypts in <i>iuGC</i> rats, n = 3, 4, 5 CTR and n = 3, 6, 3 <i>iuGC</i>. …”

Frequencies of solvent-accessible SC with a cutoff of SASA ≥5 Ų and SASA ≥0.5 Ų. by Nickolay A. Khazanov (488317)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Fenugreek exposure decreased the frequency and the alternations of the locomotor like activity. by Loubna Khalki (480082)